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Traditional prosthodontic management of partiallyedentulous patients has expanded with the introduc-tion of osseointegrated dental implants. Previous
Swedish results concerning the management of fully edentu-
lous patients1,2 have been confirmed and expanded upon by
other researchers,3-5 and more recent work has led to a lateral
shift toward trials to determine the efficacy of implants in
partially edentulous patients. The thrust of these initiatives 
has yielded several technical developments, including new
abutment designs to meet the increased esthetic demands
encountered in anterior partial edentulism and to address
problems associated with reduced bone height in posterior
partial edentulism. The premise that fewer than 5 or
6 implants can support a smaller bridge span than the one used
to replace a full edentulous arch has been well demonstrated,
albeit over the short term only.6-10 Recent research in the
Implant Prosthodontic Unit (IPU) at the University of
Toronto, Toronto, Ontario, has focused on both the effective-
ness of such treatment and the impact of selected medical
conditions on the outcome of implant treatment,10-15 to help
ensure informed decision-making by professionals and
patients alike.
The aim of this survey is to report the long-term (10- to
15-year) outcome of implant-supported posterior-zone
prostheses in the first 35 consecutive, partially edentulous
patients treated in the IPU.
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Objectif : Cet article traite des résultats à long terme des prothèses sur implant dans la zone postérieure chez les
35 premiers patients, souffrant d’édentement partiel, soignés à l’Unité de dentisterie prothétique de l’Université de
Toronto (Ontario).  
Méthodes : Un total de 106 implants dentaires Brånemark ont été placés dans 46 sextants postérieurs édentés chez
35 patients pour traiter plusieurs dents absentes. Ces patients ont fait l’objet d’un suivi prospectif. Les principes de
planification du traitement comportaient un minimum de 2 ou 3 implants pour chaque zone édentée et des concep-
tions occlusales des prothèses scrupuleuses.
Résultats : Le total des implants postérieurs survivants était de 94 %. Aucun facteur dans les antécédents des patients
n’avait nui à la survie de l’implant. 
Conclusions : Cette mise à jour clinique permet de penser que l’utilisation d’implants Brånemark pour la réhabilitation 
des patients souffrant d’édentement postérieur partiel est extrêmement efficace et que la survie des implants est
excellente.
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Materials and Methods
The charts of the first 35 consecutive patients with partial
edentulism in the posterior zone treated in the IPU, who
received a total of 46 implant-supported prostheses, were
reviewed. The patients received Brånemark dental implants
(Nobel Biocare AB, Gothenburg, Sweden), and all of them
are included in an ongoing prospective study of partially
edentulous patients that was initiated in 1983. After implant
placement, each patient’s information was stored in a central
database, which was updated regularly. Inclusion criteria
included a history of maladaptive prosthetic experience or
desire to avoid conventional removable prostheses.8 Patients
were excluded if they had a brittle medical condition or a
condition that precluded minor oral surgery, if their expecta-
tions of outcome were unrealistic, if they had a serious
psychiatric disorder, if they had a history of substance abuse or
if the quantity of the remaining bone
was insufficient to accommodate an
implant measuring 10 mm long and
3.75 mm in diameter.8 The problem of
insufficient bone occurred infrequently,
in patients with advanced resorption of
the residual ridge and unfavourable
proximity of pneumatized contents of
the sinus or inferior alveolar canal. The
implant dimensions mentioned were
those of implants available at the begin-
ning of the study. Subsequent availabil-
ity of implants 7 mm long enabled their
use as well. Treatment planning princi-
ples, which evolved on the basis of expe-
rience and published outcomes, led to
the dual objectives of a minimum of 2 or
3 implants at each edentulous site and
scrupulous occlusal prosthodontic
designs, to optimize the distribution of
anticipated stress. 
A variety of treatment options are
available for implant-supported prosthe-
ses. Figures 1a to 1d demonstrate a
routine fixed partial prosthesis supported
by an implant, which is an effective alter-
native to a removable partial denture.
Figures 2a to 2c illustrate a far more
challenging clinical situation, the management of which
demands reconciliation of traditional determinants of appro-
priate fixed prosthodontic designs, such as interarch space,
occlusal considerations, size of the edentulous occlusal span,
quality and quantity of the bone available for support, and
esthetic and oral hygiene considerations.
For this study, the patients’ edentulism fell into Kennedy
Class I, II or III, wherein 2 or more posterior teeth were miss-
ing in an edentulous span. The design of the fixed prostheses
required that occlusal loading be shared between the implants
and the natural teeth or, in certain Class I and Class II situa-
tions, that the implants bear exclusively the occlusal loading.
The distribution of the partially edentulous sites and the
opposing dentition is summarized in Table 1.
Patient management followed a set protocol. Each patient
was first screened by a prosthodontist. The medical history
was reviewed, and the presenting prosthodontic complaint was
Figure 1a: Patient’s smile reveals missing
teeth in quadrant 1.
Figure 1b: The partially edentulous span in
the right maxilla – occlusal view.
Figure 1c: After a try-in with prosthetic
teeth, an index is made and then used to
guide the technician’s wax-up of a cast
frame.
Figure 1d: A metal and ceramic fixed partial
denture was selected because of restricted
interarch space.
Table 1 Distribution of the 46 partially edentulous sites and opposing dentition in 35 patients
treated in the Implant Prosthodontic Unit, University of Toronto
Kennedy Opposing arch
Class of treated No. of partially Natural dentition Removable Implant-supported
arches edentulous sites prosthesis prosthesis
Class I 16 10 6
Class II 19 13 4 2
Class III 11 9 2
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investigated clinically and radiographically. Specifically, in
partially edentulous patients, a panoramic view taken as a
scout film was supplemented with periapical, occlusal and
tomographic radiographs to better determine the quantity and
quality of bone available for implant placement. The patient
was then presented with options, and his or her informed 
decision was obtained. If the implant option was chosen,
another appointment (with an oral surgeon) was made. At the
second consultation, the patient was again presented with all
the treatment options, and the nature of the surgical interven-
tion was discussed, including possible risks and complications
that might arise.
All patients were treated surgically by the Brånemark
method16 by graduate residents and specialist staff. The proto-
col included an intermediate healing phase, the duration of
which varied with implant location. For the posterior zone, 
the healing phase was typically 6 months. The number of
Brånemark implants placed depended on the morphological
features of the selected site, the proximity of anatomical 
structures and the expected occlusal forces.
At stage II surgery, the implant was uncovered and a
transepithelial abutment attached. Graduate residents under
the supervision of specialist staff then completed the 
prosthodontic treatment. The success or failure of osseointe-
gration was determined at stage II surgery. After completion of
the prosthodontic phase, annual follow-up visits were sched-
uled, although a number of patients did not regularly attend
their recall appointments. Recall visits consisted of an update
of the medical history, a clinical examination, removal of the
prosthesis where possible (for examination) and standardized
periapical imaging. Individual implants were examined for
signs of pain and mobility, and the health of the peri-implant
tissues was also assessed. Osseointegration was monitored clin-
ically and radiographically during these visits. The criteria used
for determining implant success were those first proposed in
198617 and subsequently revised at the Toronto consensus
conference in 1998.18 These criteria define success both at the
level of the individual implant and in terms of provision and
maintenance of functionality, from the perspectives of both
patient and dentist. All of the implant-supported prostheses
were freestanding (not attached to natural teeth).
Clinical data were collected from the patients’ dental charts,
input in a Microsoft Excel worksheet and transferred to an SPSS
statistical package (SPSS Inc., Chicago, Ill.) for analysis. Life-
table analysis was performed for overall implant survival and
also for factors that might have had an impact on implant
survival. The analysis of survival automatically excluded
implants for which data were missing (because patients did not
attend during the follow-up period). Statistical significance for
all tests was determined at p < 0.05.
Results
As of June 2000, the selected cutoff point for data entry, the
35 patients had received a total of 106 Brånemark dental
implants for the management of multiple missing teeth in 46
posterior edentulous spans. All of the patients’ updated charts
were available for analysis. As described below, these patients
originally accounted for 105 implants, but in one patient, a
failed implant was replaced with 2 implants. This accounts for
the discrepancy in total numbers of implants presented here
and in an earlier report on this cohort.7
The demographic characteristics of the patients are
presented in Table 2. The mean period of partial edentulism
before stage I surgery was 12.2 years (standard deviation 8.78)
with a range of 1 to 25 years. At the time of writing, the
patients had been followed for 10 to 15 years.
Table 3 presents additional information about the patients.
About half of the study population had a controlled medical
condition. Nonsmokers constituted 46% of all patients, and
the rest were active smokers or had a history of smoking. Nine-
teen (54%) of the patients had implants placed in the
mandible. As outlined above, 105 implants were placed origi-
nally. Of these, 2 “sleeper” implants were not used in the final
prosthesis designs because of their unfavourable location. Six
implants had been lost by the time this report was prepared.
Two were early failures diagnosed at stage II surgery, and the
other 4 were late failures, diagnosed 2 to 7 years after loading.
Three of these late failures were due to implant fracture rather
Table 2 Demographic characteristics of 35
partially edentulous patients treated
in the Implant Prosthodontic Unit,
University of Toronto
Men Women
No. of patients 11 24
Mean at stage I surgery 47.1 45.2
Range 30–64 20–65
Maxilla 3 13
Mandible 8 11
Table 3 Medical characteristics of 35 partially
edentulous patients treated in the
Implant Prosthodontic Unit, Univer-
sity of Toronto
Variable No. (and %) of patientsa
Medical status
Healthy 16 (46)
Medical condition present 19 (54)
Medication use
No medications 17 (49)
Medications used 18 (51)
Smoking status
Active smokers 7 (20)
Nonsmokers 16 (46)
Former smokers 9 (26)
Missing data 3 (9)
Site for fixed prostheses (n = 46)
Maxilla 17 (37)
Mandible 29 (63)
aExcept where indicated otherwise.
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Table 4 Impact of implant failure on prosthodontic outcomes 
Prosthodontic outcome
Type of failure No. of implants Implant Implant Tissue integrated,
affected replaced not replaced prosthesis lost
Sleeper implants* 2 0 0
Loss of implant 4 in total
Early 2 1 1 (due to late failures)
Late 4 4 0
*Unfavourable placement of implant precluded its use.
Table 5 Average survival time of 106 dental implants in relation to various factors in 35 patients
with partial edentulism treated in the Implant Prosthodontic Unit, University of Toronto
(Kaplan Meier method)
Survival (years) p value
Variable No. of implants Mean SE Log–rank test Breslow test
Sex
Male 32 13.7 0.6 0.071 0.616
Female 74 14.7 0.2
Smoking
Group 1 (active and former smokers) 46 14.3 0.4 0.792 0.822
Group 2 (nonsmokers) 60 14.4 0.4
Medical condition
Present 61 14.5 0.3 0.667 0.662
Absent (healthy patient) 45 14.3 0.4
Long-term use of medications
Yes 58 14.4 0.4 0.987 0.993
No 48 14.0 0.4
Jawbone
Maxilla 42 14.6 0.3 0.560 0.529
Mandible 64 14.2 0.4
Bone qualitya
1 0 — — 0.618 0.676
2 23 13.7 0.3
3b 54 14.3 0.4
4 13 — —
Bone quantitya
A 11 — — 0.619 0.676
Bb 38 14.6 0.4
C 37 14.3 0.4
D 4 — —
Period of edentulism (years)a
Group 1 (lowest up to 10 years)b 36 14.1 0.6 0.510 0.580
Group 2 (11 years to highest) 33 14.4 0.3
State of opposing dentition
Natural or restored teeth 94 14.3 0.3 0.652 0.656
Removable partial denture 3 — —
Complete denture 9 — —
Implant length (mm)a
7.0b 12 — —
10.0 53 14.3 0.4 0.858 0.874
13.0 22 14.1 0.7
15.0 3 14.3 0.6
18.0b 16 — —
SE = standard error
aMissing data were not included in analysis (and therefore implant numbers do not sum to 106).
bFailure did not occur; mean survival time cannot be computed.
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than loss of osseointegration. The cause of the fractures is
unknown, and they could not be correlated with bone levels
around the implants. The 4 implant failures compromised
prosthetic function and necessitated replacement (Table 4). In
one patient, a single original implant was replaced with
2 implants after an appropriate healing phase. At the most
recent clinical assessments, evaluations by both patients and
dentists indicated successful prosthodontic results, in accordance
with the success criteria proposed by Zarb and Albrektsson.18
The role of various patient factors on implant survival were
analyzed (Table 5). None of these factors adversely affected
implant survival in this patient group. In contrast, Wyatt,19
using similar criteria for a larger group of patients from the
IPU database, reported a higher failure rate (25%) for
7-mm fixtures. 
A graph based on a life-table analysis is presented in
Fig. 3. The overall survival of implants in the posterior zones
of both maxilla and mandible was 94% (92% if the 2 sleepers
are regarded as failures). The difference in survival rate
between men and women was not statistically significant at
any point (p = 0.061) (Fig. 3). However, the graph suggests
that the survival rate was lower for men 15 years after loading
(88% in men and 97% in women).
Discussion
This study reports on the surgical and prosthodontic
outcomes of Brånemark implants supporting fixed prostheses
placed in the posterior zone of the first 35 partially edentulous
patients treated in the IPU. This survey is part of an ongoing
prospective study initiated in 1983 at the University of
Toronto.
The benefits of employing the maximum number
of implants possible (3 whenever feasible) plus strict
adherence to Beyron’s therapeutic occlusal objectives20-22
appeared to be underscored by the outcomes reported here.
The cumulative survival rate for Brånemark implants in the
posterior zone was 94% after 10 years of observation, which
compares favourably with the survival rate of 92.6% reported
by Lekholm and others.23 Although there was no statistical
difference between men and women, the trend in the data
suggested that overall survival was lower for men. Six (5.7%)
of the implants failed. Two (1.9%) of these were early failures,
that is, the implants had not osseointegrated. These propor-
tions are comparable to the results published by Esposito and
others,24 who reported an overall failure rate of 3.8% in partial
edentulism and a 2% early failure rate.
The condition of the marginal bone around the implants
was not determined for this survey. Wyatt8 previously
reported that annual loss of marginal bone among partially
edentulous patients treated in the IPU was well within the
suggested maximum of 0.2 mm after the first year of func-
tion. However, Wyatt,8 reporting on the outcomes of
implant-supported fixed partial dentures, noted that 15% of
the patients in his study experienced bone loss exceeding
0.2 mm per year. This level of bone loss typically occurred in
Figure 2a: The left mandibular dentition and
its supporting tissues were lost after surgical
resection for treatment of a tumour. The
grafted site hosts 4 long implants placed in
an offset manner to optimize lateral stress
resistance.
Figure 2b: Interarch space allowed for use
of stock prosthetic teeth attached to a
silver–palladium framework.
Figure 2c: The casting technique is similar
to the one used when designing saddle
areas for removable partial dentures. The
favourable circumoral activity allows for
generous space under the pontics and
around the implant abutments for
maintenance of hygiene.
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Figure 3: Overall survival of dental implants in 35 consecutive
patients with posterior partial edentulisum treated in the Implant
Prosthodontic Unit at the University of Toronto. Time zero is the time
of stage I surgery. There was no difference between men and women
(Wilcoxon test, p = 0.061). 
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the mandible of younger male patients after one year of 
loading, and was more frequent when the prosthetic design
included a posterior cantilevered pontic.
A number of practical considerations may have implica-
tions for the results reported here.
1. The limited sizes of implants that were available initially
prevented the IPU from treating patients whose posterior
edentulous sites had significant quantitative deficits (bone
height < 7 mm). Consequently, the observations reported
here apply exclusively to implant abutments of 10 mm or
longer with occasional adjunctive support from a 7-mm
implant. Therefore, our results cannot be extrapolated to
sites where the deficit status could be improved by localized
tissue engineering, augmentation or use of wider (if shorter)
implants. All these options may prove to be of compelling
significance. However, evidence for the use of such implants
is lacking at this stage, and we can only report that support
from multiple implants, mainly 10 mm or more in length
and 3.75 mm in diameter, has proven efficacious and
effective.
2. Our success with freestanding implant-supported prosthe-
ses should not be construed as negating the impressive
results reported by researchers in Umea, Sweden. Gunne
and others25 have provided data to support the use of short-
span fixed prostheses supported by one implant and one
tooth. Their results are particularly significant in the
context of a shortened dental arch26 approach to posterior
partial edentulism.
3. Although comprehensive quantitative studies reflecting
patient satisfaction with implant therapy are unavailable for
this patient group, traditional and time-proven indications
of patient satisfaction were acquired through simple 
questioning. All of the patients were pleased with the
results of their treatment and were free of the morbidity
that is sometimes associated with surgical intervention for
implant treatment.
4. The restorative materials used here could not be correlated
with previously recorded outcomes. Consequently, as with
most decision-making in prosthodontics, the choice of
materials was made on the basis of interarch space available,
other technical and esthetic dictates and, occasionally,
patient input. These subjective yet prudent judgements
appear to have served us well in the choice of prosthodon-
tic materials for these patients.
Conclusions
This clinical update suggests that the use of Brånemark
implants in the rehabilitation of patients who are partially
edentulous in the posterior zone is highly effective and is asso-
ciated with excellent survival rates. However, it seems prudent
to underscore the fact that these outcomes were obtained in a
university clinic under the supervision of specialists, with
stringent treatment planning and clinical examination, as part
of an evidence-based approach to clinical decision-making in
prosthodontics. C
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